The association of ALDH1A1 and ALDH2 RNA expression levels with risk group classification and survival in patients with primary AML draws conclusions from a large sample size (>1000 patients) over nine independent cohorts (eight cohorts with risk information and eight cohorts with survival information), and therefore, they cannot be ignored. The gene discussed is ALDH2; the disease is acute myeloid leukemia.